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Highlights: 
 Elevated thalamic GABA levels were found in active welders using MRS  
 
 Brain manganese deposition assessed by MRI was significantly higher in all welders 
 
 The thalamic GABA levels were associated with Mn exposure and brain Mn deposition 
 
 There appears to be an exposure threshold for effects on GABA and motor performance  
 
 Only high-exposure welders showed significantly worse motor performance 
 
 
 
Abstract: 
Excessive occupational exposure to Manganese (Mn) has been associated with clinical symptoms resembling 
idiopathic Parkinson’s disease (IPD), impairing cognitive and motor functions. Several studies point towards an 
involvement of the brain neurotransmitter system in Mn intoxication, which is hypothesized to be disturbed prior 
to onset of symptoms. Edited Magnetic Resonance Spectroscopy (MRS) offers the unique possibility to 
measure γ-amminobutyric acid (GABA) and other neurometabolites in vivo non-invasively in workers exposed 
to Mn. In addition, the property of Mn as Magnetic Resonance Imaging (MRI) contrast agent may be used to 
study Mn deposition in the human brain. In this study, using MRI, MRS, personal air sampling at the working 
place, work history questionnaires, and neurological assessment (UPDRS-III), the effects of chronic Mn 
exposure on the thalamic GABAergic system was studied in a group of welders (N=39) with exposure to Mn 
fumes in a typical occupational setting. Two subgroups of welders with different exposure levels (Low: N = 26; 
mean air Mn = 0.13±0.1 mg/m3; High: N = 13; mean air Mn = 0.23±0.18 mg/m3), as well as unexposed control 
workers (N = 22, mean air Mn = 0.002±0.001 mg/m3) were recruited. The group of welders with higher 
exposure showed a significant increase of thalamic GABA levels by 45% (p<0.01, F(1,33) = 9.55), as well as 
significantly worse performance in general motor function (p < 0.01, F(1,33) = 11.35). However, welders with 
lower exposure did not differ from the controls in GABA levels or motor performance. Further, in welders the 
thalamic GABA levels were best predicted by past-12-months exposure levels and were influenced by the Mn 
deposition in the substantia nigra and globus pallidus. Importantly, both thalamic GABA levels and motor 
function displayed a non-linear pattern of response to Mn exposure, suggesting a threshold effect.  
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1.  Introduction 
Manganese (Mn) is an essential trace mineral for regulating human metabolism. In the central nervous system 
(CNS), Mn functions as a cofactor for several key enzymes (Aschner and Aschner ,2005; Aschner et al., 1992; 
Bouabid et al., 2016). Over-exposure to Mn in occupational settings may lead to neurotoxic effects affecting 
cognitive, psychiatric and motor functions, characterized as parkinsonian symptoms, and could develop into 
manganism in severe cases (Couper, 1837; Ellingsen et al., 2008; Guilarte and Chen, 2007; Klos et al, 2006; 
Lucchini 1995). Even with a relatively low level of exposure under or approaching the American Conference of 
Governmental Industrial Hygienists (ACGIH) Threshold Limit Value (TLV) before 2013 (0.2 mg/m3), subtle 
neuropsychological deficits were still observable (Roels et al., 2012; Bowler et al.,2011). In 2013, a ten-fold 
reduction of the ACGIH TLV for respirable Mn exposure levels was introduced. However, there has been a gap 
connecting individual Mn exposure levels with physiological changes to provide an assessment of a safe level 
of exposure below which no significant adverse physiological and behavioral effects would be of concern. A 
marker that may aid to establish such a connection is therefore desired. 
Excessive exposure to Mn can cause a variety of effects on brain physiology.  Animal studies have shown that 
the primary targets of Mn include the striatum and globus pallidus in the basal ganglia (Zheng et al., 1998). Mn 
overexposure has been associated with affecting dopamine (DA) neurotransmission in the striatum (Guilarte et 
al., 2008), enhancing oxidative stress and interfering with calcium and iron homeostasis in mitochondria in the 
basal ganglia (Tuschl et al., 2013), as well as abnormalities in glutamatergic and GABAergic transmissions 
(Racette et al., 2012), the primary excitatory and inhibitory projections within the basal ganglia neuronal 
pathways.   
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Gamma aminobutyric acid (GABA) plays a key role in mediating the direct and indirect pathway of the basal 
ganglia (Graybiel, 2000), both of which have GABAergic projections to the thalamus, which then propagate to 
cortical regions (Kropotova and Etlingerb, 1999). The ganglia-thalamo-cortical pathway is mainly involved in 
voluntarily movement as well as in emotions, motivation and cognition that drive the movement (Everitt and 
Robbins, 2005, Haber and Calzavara, 2009). Despite the similarity in clinical manifestations between Mn-
induced Parkinsonism and idiopathic Parkinson’s disease (IPD), the mechanism and the affected structures in 
the basal ganglia are quite different (Olanow, 2004). Focusing on disruptions of the neurotransmitter system, 
animal studies have shown controversial conclusions as reviewed by Burton and Guilarte (2009), suggesting 
that the consequences of the disruption of the neurochemical system in the CNS due to Mn toxicity might 
depend on multiple factors including dose, length of exposure duration as well as how Mn is introduced to the 
CNS. Our previous study has found elevated thalamic GABA levels in a group of smelters with relatively high 
Mn exposure levels (Dydak et al, 2011). Moreover, the increase in GABA levels was found to be strongly 
associated with fine motor function (Long et al. 2014b). These results from relatively high exposure settings 
motivated the further investigation of the relation between individual Mn exposure levels and alterations of 
brain GABA levels, to advance the understanding of the mechanism of Mn neurotoxicity in the human brain 
and to test whether in vivo GABA levels may serve as marker of neurotoxic effects. Of particular interest is 
whether alterations in GABA levels due to Mn exposure also exist in a typical occupational setting in the US 
with individual respirable Mn air levels ranging from ~0.05 to 0.5 mg/m3. 
One typical difference in Mn-induced parkinsonism as compared to IPD is the absence of resting tremor (Guilarte, 
2010). In addition, kinetic tremor has been reported to be more common in Mn-induced parkinsonism compared 
to IPD (Cersosimo and Koller, 2005). Widespread rigidity appears to be one of the common symptoms shared 
by both, manganism and IPD (Standwood et al., 2009). The thalamus is known to be involved in both tremor and 
rigidity, but controlled by different neuronal pathways (Herrero MT et al., 2002).  Tremor can be triggered by both 
basal ganglia and cerebellar input influencing thalamo-cortical interactions, while rigidity is considered to be more 
involved with basal ganglia and motor thalamus (Carr, 2002, Rodriguez-Oroz et al., 2009). Rigidity and tremor 
both have been widely studied in IPD cases (Bergman and Deuschl, 2002, Helmich et al., 2013, DeLong and 
Wichmann, 2007, Prochazka et al., 1997). However, the association between clinical rigidity and tremor and Mn-
induced disruption of brain GABA has not been previously examined.  Examining these associations could help 
 5 
clarify mechanisms of Mn neurotoxicity, and perhaps help to distinguish these from the clinical characteristics of 
IPD.  
Due to the paramagnetic properties of Mn, brain Mn deposition alters the longitudinal relaxation rate (R1) and 
thus the T1 (=1/R1) contrast measured by magnetic resonance imaging (MRI). R1 has been suggested to be 
linearly proportional to tissue Mn deposition in animal models with high exposures (Chuang et al., 2009, 
Fitanakis et al., 2006). As brain GABA levels may be detected non-invasively in vivo using MEGA-edited 
magnetic resonance spectroscopy (MRS) (Mullins et al., 2014), investigating the association between R1 
values and GABA levels provides a direct and practical approach to study the effect of brain Mn levels on the 
GABAergic system. 
A shortcoming of most neuroimaging studies on occupational Mn exposure is the lack of information on individual 
exposure to Mn. In some cases, a very crude approximation is made by simply using reported welding hours 
(e.g. Lee et al., 2015). In others exposure is estimated from models using information obtained through work 
history questionnaires (e.g. Racette et al., 2012). However, work settings constantly change and exposure levels 
are dependent on factors including metal type, enclosure and ventilation condition of the work space, time period, 
filter location, and perhaps other factors. (Hobson et al. 2011). The respirable fraction of airborne Mn, sampled 
from the air within the welding helmet, is expected to best represent individual exposure levels (Harris et al. 
2005).  According to literature reports, since 2000, the mean airborne Mn levels for various cohorts across the 
world spans a rather large range from 0.062 mg/m3 to 0.49 mg/m3 (Ellingsen et al. 2006, Pesch et al. 2012, 
Bowler et al. 2007, Smargiassi et al. 2000). Therefore, in this study personal air sampling at the working place 
was used, which should provide the most accurate information on individual exposure levels.  
In this study, a group of Mn-exposed welders and matched control subjects without Mn exposure were recruited 
and examined using MRI, MRS, personal air sampling at the working place, work history questionnaires, and 
neurological assessment. The study aimed at investigating the response of in vivo GABA levels in thalamic and 
striatal brain regions, measured by MRS, to 1) individual Mn exposure levels, 2) R1 values measured by MRI 
and indicative of brain Mn deposition, and 3) motor performance, including tremor and rigidity, determined by 
the Unified Parkinson’s Disease Rating Scale III (UPDRS III). 
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2. Material and Methods 
2.1. Subject recruitment: 
Male welders (N=39) and age-matched male control subjects (N=22) were recruited from a truck trailer 
manufacturer in the U.S. Welders had to be welding for at least 3 years at this factory to be eligible to participate. 
Control subjects were recruited from the same factory and had not been exposed to welding fumes (e.g. working 
in assembly lines). None of the subjects had any history of neurological or psychiatric disorder. The study was 
approved by the Institutional Review Board at Purdue University. Written informed consent forms were obtained 
from all subjects prior to the participation in the study. As it was noticed during the study that some welders had 
significantly higher individual exposure levels due to factors including higher airborne Mn exposure and more 
confined welding space, the welders were further grouped into two subgroups, noted as higher exposure group 
(HEX) and lower exposure group (LEX). The grouping was based on the recent exposure level of each subject 
represented by the past-3-months individual exposure level calculated by an exposure model further described 
in section 2.2.  Welders with past-3-months exposure levels higher than 0.04 mg/m3·year were grouped into the 
HEX subgroup, as shown in Fig. 1. This exposure level translates to an average annual exposure to an airborne 
Mn level of 0.16 mg/m3. All other welders were grouped into the LEX subgroup. Mean age, mean airborne Mn 
levels and years of welding of all subjects are listed in Table 1. As a first study of this population, the selected 
threshold was relatively arbitrary and initially informed by a clear difference in past-three-months exposure 
between subjects from the two plants of the factory tested. While the plant-defined difference with regard to 
worker exposures was not maintained over the course of recruitment due to wearing of respirators or other non-
plant specific factors, this threshold nonetheless was maintained to separate the two subgroups. 
All subjects visited a local imaging center for approximately four hours on a weekend day, where they were 
interviewed about their medical history, life habits (e.g. diet, smoking, drinking), and about their work history. 
Further, they performed a battery of motor and cognitive tests (this paper will only report on motor tests) and 
received an MRI scan of approximately 1 hour. Personal air sampling was performed on each subject during a 
full 8-hour shift at their work place on a weekday following their MRI exam.  
--------------------------------------- 
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2.2. Exposure Assessment: 
An exposure model was developed to estimate each participant’s cumulative exposure index (CEI) as an 
estimate of the individual cumulative respirable (<4µm diameter) airborne Mn exposure for different time windows, 
which was derived from personal air samples as described below. For all subjects, high- and low-exposure, our 
sampling procedure used SKC aluminum cyclones with a cut-point of 4μm, which collect the respirable particles 
capable of penetrating to the alveolar regions of the lungs as well as deposit in the brain via the olfactory pathway. 
Our sampling procedure was conceived primarily for measurements of direct personal exposure of welders, 
however as each subject was wearing the device for the length of his shift, also exposure to the ambient 
conditions present in the department was measured. Unpublished data on particle size distributions present in 
the ambient air at the factory, using an electrical low-pressure impactor (ELPI), showed that the ambient air at 
the factory typically contains less than ~10,000 particles/cm3 and that particle number concentrations were 
dominated by particles less than 2μm in size (aerodynamic diameter). In contrast, exposure inside the welding 
helmet was extremely high (>1,000,000) particles/cm3), several orders of magnitude above ambient levels, and 
particles were small, ranging from 10nm-300nm. This shows that our sampling procedure is valid for both 
ambient and personal exposure. Furthermore, it shows that most exposure present for our cohort came directly 
from personal exposure to welding fume and not from ambient conditions. Therefore, the only difference between 
the HEX and LEX groups was the amount of direct personal exposure to welding fume. 
 
The following exposure time windows were used in this study: exposure over the past three months (before the 
MRI measurement), exposure over the past year, and cumulative exposure over their working lifetime (back to 
age 18). For each case the CEI is calculated as a summation of the individual exposure from the current employer 
(CEICE), past employers (CEIPE) and off the job welding (CEIOJ) for the given exposure window in (mg/m3)·years 
as seen in equation 1 below (Ward et al. 2015). 
                  CEI (mg/m3·yr) = CEICE + CEIPE + CEIOJ    [Eq. 1] 
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Our exposure model utilizes personal air sampling of respirable Mn, averaged to respirable Mn concentrations 
per department (working site within the factory). The average concentrations of respirable Mn were gathered 
from seventy-seven personal air samples with an average of six air samples per department to have accurate 
measures of exposure for each working site within the factory. Each personal air sample was collected over the 
duration of a full work shift (8 hours). The samples were collected inside the welding helmet for welders and on 
the shoulder in the personal breathing zone (PBZ) for control subjects. The CEI for the current employer is then 
calculated by summing over the measured average respirable Mn exposure for each department an individual 
has worked in during the respective time window, multiplied by the time worked at this department. For 
cumulative exposure including past employers or for off-the-job welding, the exposure model utilizes additional 
information from a detailed work history questionnaire, as well as weighting factors accounting for ventilation, 
welding frequency, welding type, base metals and use of respirator to better estimate the individual’s exposure 
based on personal history (Laohaudomchok et al. 2011). These weighting factors were developed by Hobson et 
al. (2011) in a previous study investigating sixty-six other studies on how each of these factors changes Mn 
exposure. Overall, our exposure model gives estimates for the lifetime airborne respirable Mn exposure the 
individual may have had, as well as for respirable Mn exposure over the past three months and over the past 
year. 
2.3. GABA MRS acquisition and analysis: 
MRI and MRS exams were performed using a 3T GE Signa MRI scanner equipped with an 8-channel head coil. 
A high-resolution 3D T1-weighted FSPGR sequence (TR/TE=6.26/2.67 ms, resolution: 1×1×1 mm3) was 
followed by a fast T2-weighted sequence, acquiring sagittal and axial images aligned with the anterior and 
posterior commissure (AC/PC) for accurate placement of the MRS volumes of interest (VOIs). GABA spectra 
were acquired using the MEGA-PRESS sequence (TR/TE=2000/68 ms) (Mullins et al., 2014) with the editing 
pulses centered on 1.9 ppm (edit ON) and 7.5 ppm (edit OFF). 256 averages were acquired for edit ON and edit 
OFF spectra in an interleaved fashion. 8 averages of water reference scans without water suppression were 
acquired for frequency and phase correction. To determine the thalamic GABA level the MRS VOI was centered 
on the right thalamic region (25 mm × 30 mm × 25 mm) as shown in Fig. 2. The same GABA-edited MRS 
measurement was also performed on the right corpus striatal region (25 mm × 30 mm × 25 mm), which is referred 
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to as the striatal region in this paper, including globus pallidus and a part of putamen and caudate nucleus. This 
VOI intentionally overlapped partly with the thalamus VOI to detect or rule out a possible influence from striatal 
GABA signal to the large voxel size of the thalamic VOI.  
--------------------------------------- 
-------------------------------------- 
Edit ON and OFF spectra were first post-processed with a Matlab 2013a (The MathWorks, Natick, 2013) tool to 
perform coil combination, zero and first order phase correction, as well as frame-by-frame spectral alignment. 
Difference spectra obtained from subtracting the averaged OFF spectra from the averaged ON spectra, showing 
a GABA peak at 3 ppm, were quantified using LCModel V6.3-1B (Provencher, 1993). A basis set generated by 
density matrix simulation using GABA coupling constants from Kaiser et al. (2008) was used. The examples of 
GABA-edited spectra from the thalamus and the striatum fitted by LCModel are shown in Fig. 2. 3D T1-weighted 
images were segmented into grey matter (GM), white matter (WM) and cerebrospinal fluid (CSF) using statistical 
parametric mapping (SPM8, Wellcome Department of Imaging Neuroscience, London, United Kingdom). The 
percentages of GM, WM and CSF for each VOI were then calculated from the tissue probability maps with a 
home-made Matlab (The MathWorks, Natick, MA) code. Since CSF has a near-zero concentration of GABA and 
other metabolites, GABA levels were corrected for CSF to obtain tissue GABA concentrations. Examples of 
tissue maps of GM, WM and CSF overlaid with the GABA VOIs are shown in Fig. 2. A widely-used approach in 
the MRS literature expressed by the following equation (Chowdhury et al., 2015) was applied to obtain the CSF-
corrected tissue GABA levels from each VOI:  
𝑀𝑐𝑜𝑟 = (𝑀𝑟𝑎𝑤)  ×
35880×(𝑓𝐺𝑀+𝑓𝑊𝑀)+55556×𝑓𝐶𝑆𝐹
35880
×
1
1−𝑓𝐶𝑆𝐹
      [Eq. 2] 
2.4. R1 ROI analysis: 
Averaged R1 values for different brain regions were calculated based on T1 relaxation time maps. Whole brain 
3D T1 relaxation time mapping was performed using the dual flip angle technique (Christensen et al., 1974) to 
assess brain Mn accumulation. Two spoiled gradient echo images (SPGR, TR/TE6.36/1.76 ms, 
bandwidth=224Hz/pixel, matrix dimension=256 x 192, resolution: 1×1×2 mm3) with flip angles 3º and 17 º were 
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acquired. An inversion recovery sequence (IR-SPGR, TI=250ms) with the same parameters as the dual flip angle 
sequences was used to correct for inhomogeneity of the radiofrequency field (Deoni, 2007). T1 values were 
calculated for each pixel based on repetition time (TR), flip angle (α) and a factor that is proportional to the 
equilibrium longitudinal magnetization (ρ) using equation 3 (Sabati and Maudsley, 2013), with T1 maps 
generated by an in-house program in Matlab ():  
𝑆𝑆𝑃𝐺𝑅 =
𝜌(1−𝐸1) sin 𝛼
1−𝐸1 cos 𝛼
,           𝑤ℎ𝑒𝑟𝑒 𝐸1 = 𝑒
−𝑇𝑅/𝑇1     [Eq. 3] 
First, T1 values were measured for brain regions of interest (ROIs) in the globus pallidus, substantia nigra, 
caudate, and frontal cortex, which were reported to have high Mn deposition by Criswell et al. (2012). Circular 
ROIs with an area of 30 mm2 were measured bilaterally on T1 maps, using the ROI tool in Matlab and Osirix 
(Pixmeo, Switzerland), as shown in Fig. 3. Second, R1 values of the above ROIs were calculated as the inverse 
T1 relaxation time. Finally, R1 values from left and right hemispheres were averaged for every brain structure. 
--------------------------------------- 
-------------------------------------- 
 
2.5. Motor function examination: 
Motor performance of the subjects was tested with the Unified Parkinson’s Disease Rating Scale - Part III 
(UPDRS-III), which is a comprehensive evaluation of motor function used clinically to test severity of disease in 
patients with Parkinson Disease (Goetz et al, 2007). The examination was performed by a certified neurologist 
(S.E.Z.) for all subjects. Rigidity scores were calculated as the summation of 5 items: rigidity in the neck, rigidity 
in the left upper extremity (LUE), rigidity in the right upper extremity (RUE), rigidity in the left lower extremity 
(LLE) and rigidity in the right lower extremity (RLE). Tremor scores were calculated as the summation of 7 items: 
left and right kinetic tremor of the hands, rest tremor amplitude in lip/jaw, RUE, LUE, RLE and LLE. A higher 
UPDRS score indicates a worse motor performance. UPDRS scores up to 15 are considered within the normal 
range. 
 11 
2.6. Statistical analysis: 
Subjects were grouped into controls, welders from the HEX group, welders from the LEX group and all welders 
as a whole. Normality of each variable was tested using the Shapiro-Wilk test. All variables investigated were 
found to be normally distributed with p values from the Shapiro-Wilk test larger than 0.05. The differences of the 
measured variables between Mn-exposed groups and controls, as well as between welders in the HEX and LEX 
groups were examined using an analysis of variance (ANOVA) followed by Fisher’s least significant difference 
(LSD) post hoc tests. A false discovery rate with q-value < 0.10 was used as a cutoff to control for multiple 
comparisons (Benjamini and Hochberg,1995).  
For correlation analysis, two hypotheses were tested: a) thalamic GABA levels are related to Mn exposure levels 
and to R1 values indicative of brain Mn deposition; b) motor function reflected by UPDRS total score, rigidity 
score and tremor score is related to thalamic and striatal GABA levels. For each hypothesis, pairwise Pearson 
correlation analysis was performed to test for correlations between all variables, followed by regression analysis 
with exhaustive model selection based on adjusted R-square. Type III sum of square (SS) for each dependent 
variable from the full models were calculated to examine the effect from each variable after considering all other 
variables.  Highly correlated independent variables, such as past-3-months and past-12-months exposure levels, 
were not added to the same full model to avoid multicollinearity. For each independent variable in the final models 
the Variance Inflation Factor (VIF) was calculated to assess potential multicollinearity issues. A VIF below 2 
indicates that the association with other dependent variables could be neglected in this study. No regression 
analysis was performed in controls due to the fact that their airborne exposure levels were close to or below the 
detection limit. 
 
 
3. Results: 
3.1. Group differences: 
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Table 2 presents the mean values and the standard deviation of 1) past-3-months, past-12-months and 
cumulative individual exposure levels, 2) GABA levels in the thalamus and striatum, 3) R1 values from the globus 
pallidus, substantia nigra, caudate nucleus and frontal cortex, 4) UPDRS total score, rigidity score and tremor 
score in all groups, as well as the p-values from group comparison tests. Respirable air Mn levels for welders 
ranged from 0.05 mg/m3 to 0.53 mg/m3. Welders had significantly higher exposure levels compared to the 
controls (p<0.001). Furthermore, the welders from the HEX group had significantly higher past-3-months, past-
12-months (p<0.001) and cumulative (p<0.05) Mn exposure levels than welders from the LEX group.  
Thalamic GABA levels were significantly elevated in HEX welders compared to the controls (p<0.01) and to LEX 
welders (p<0.01). However, there was no significant difference between LEX welders and controls. In some 
welders, a hyperintensity in the globus pallidus was observed in T1-weighted images (Fig. 5). For all welders, 
increased R1 values, indicating higher Mn deposition, were found in the globus pallidus (p<0.01), caudate 
nucleus (p<0.05) and frontal cortex (p<0.01) compared to control subjects. HEX welders had a higher R1 in the 
globus pallidus (p<0.001), substantia nigra (p<0.05), caudate nucleus (p<0.05) and frontal cortex (p<0.01). LEX 
welders only had a higher R1 in the globus pallidus (p<0.01) and frontal cortex (p<0.001). Differences in R1 
values between the two welder subgroups were not significant.  
UPDRS scores were significantly higher in HEX welders compared to the controls (p<0.01). No group difference 
in rigidity scores across groups was found. HEX welders had significantly higher tremor scores compared to LEX 
welders (p<0.01) and controls (p<0.05). It is worth noticing that all of our subjects had a rest tremor score of zero, 
indicating no rest tremor symptoms at all. Therefore, the tremor scores listed here are pure kinetic tremor scores. 
Fig. 6 shows the main findings on GABA levels, exposure levels, R1 levels indicating brain Mn deposition, and 
motor function across the three groups. 
 
 
--------------------------------------- 
--------------------------------------- 
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3.2. Regression analysis: 
The results of pairwise Pearson correlation analysis for each of the tested hypotheses are presented in Tables 
3.1 and 3.2. Specifically, for the first hypothesis (thalamic GABA levels are related to Mn exposure levels and to 
R1 values indicative of brain Mn deposition), past-3-months and past-12-months exposure levels were highly 
correlated (r = 0.77, p < 0.0001). In addition, past-12-months exposure showed the most significant correlation 
with thalamic GABA, (r = 0.47, p = 0.02). The scatter plot for thalamic GABA levels and past-12-month exposure 
levels is shown in Fig. 6. The full model for this hypothesis hence only included the past-1-year exposure levels, 
cumulative exposure levels, R1 values from all of the 4 measured brain regions and age.  
--------------------------------------- 
--------------------------------------- 
Although the inter-correlations between R1 values from all of the 4 brain regions were significant, these are most 
likely driven by Mn distributing throughout the brain in multiple brain regions and thus affecting R1 in all tested 
brain regions. A subject with more Mn exposure and higher R1 value in one brain region is likely to have higher 
brain R1 values across the brain. Therefore, the full regression model did not exclude R1 from any of the brain 
regions we measured. Age was added as an independent variable for each model because brain GABA levels 
have been reported to be related to age (Gao et al, 2013).  
Tables 4.1 and 4.2 list the Type III SS of each variable from the full regression models on thalamic (table 4.1) 
and striatal (table 4.2) GABA, as well as their F and p values. The final model selected for the regression of the 
thalamic GABA levels on exposure levels and R1 values included past-12-months exposure levels, R1 from 
globus pallidus, R1 from substantia nigra and age as independent variables. The selected model for the 
regression of striatal GABA levels on exposure levels and R1 values included past-12-months exposure levels, 
R1 from frontal cortex, R1 from substantia nigra and age as independent variables. The results of the final models 
are listed in table 4.1 for thalamic GABA levels and in table 4.4 for striatal GABA levels. 
-------------------------------------- 
-------------------------------------- 
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This analysis reveals a statistically significant relation between thalamic GABA levels in welders and past-12-
months exposure, R1 values from the globus pallidus, substantia nigra, and age. The VIF of all independent 
variables were below 2, indicating negligible multicollinearity. The striatal GABA levels were significantly related 
to R1 values from frontal cortex and substantia nigra, and to age. However, in this case the VIF of the R1 values 
from the two brain regions were higher than 2, indicating a potential multicollinearity issue.  As can be seen from 
Table 4.2, only R1 values from the frontal cortex and age significantly (p < 0.05) improved model fitting.  
 
For the second hypothesis (motor function reflected by UPDRS total score, rigidity score and tremor score is 
related to thalamic and striatal GABA levels), no significant correlation was found between thalamic GABA, 
striatal GABA and age by pairwise Pearson analysis (Table 3.2). Therefore, thalamic GABA, striatal GABA and 
age were all included in the full regression model. One type of motor function was examined at one time as the 
dependent variable. Thus, three regression analyses with model selection procedure were performed. 
Statistical analyses results for the regression of UPDRS score on GABA and age are presented in Table 5.1 for 
Type III SS analysis and Table 5.2 for the final model summary. The p-values of independent variables indicate 
that only age is statistically significant in the final model. In addition, two separate regression models were 
conducted for rigidity score and tremor score, with statistical results presented in Tables 5.3 and 5.4, respectively. 
The results indicate a lack of any statistically significant relationship between GABA levels, age and rigidity score. 
Equally there is no significant relationship to tremor scores as indicated by the p-values listed in Table 5.4.   
--------------------------------------- 
-------------------------------------- 
 
4. Discussion: 
In this study, chronic increased exposure to Mn in an occupational setting is found to affect the GABAergic 
system. The significantly elevated thalamic GABA levels in Mn-exposed welders with relatively high exposure 
(>0.04 mg/m3·yr over the past 3 months) confirm the results reported in earlier studies from Dydak et al. (2011) 
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and Long et al. (2014) conducted in China, but in a lower-exposure occupational setting than the previous studies.  
The fact that no difference was observed for the striatal VOI further confirmed that the signal change in GABA 
in the thalamic VOI came from the thalamus rather than from the part of the globus pallidus included in the 
thalamic VOI. In rodent studies alterations of GABA levels were observed in other brain regions such as the 
striatum (Gwiazda et al. 2002) and cerebellum (Lipe et al., 1999). However, studies on non-human primates 
yielded no change in brain GABA concentration under Mn exposure (Burton and Guilarte et al., 2009, Struve et 
al. 2007). These discrepancies suggest that the effects of Mn on the GABAergic system are complex. Species 
differences, length of exposure duration and delivery method could all play a role in the effect of Mn neurotoxicity. 
Furthermore, GABA levels were measured ex vivo in these animal studies, whereas all human MRS studies 
yield in vivo GABA levels, including signal from both synaptic and intracellular GABA.  
In our study, welders with lower exposure, though with higher exposure level than controls, had similar GABA 
levels as controls. We therefore hypothesize that there could be a threshold level of individual Mn exposure that 
needs to be surpassed to cause a significant change in GABA levels in the thalamus. Pharmacokinetic studies 
on Mn modeling (Nong A. et al., 2008, Nong A. et al., 2009, Schroeter et al., 2011) suggested that Mn 
accumulation in tissue could be observed when inhaling Mn at exposure levels over 0.1 mg/m3. According to this 
pattern of the brain tissue’s response to Mn exposure, it is reasonable that also a neurochemical alteration will 
only occur beyond a similar level of Mn exposure. According to the present study, extrapolating our arbitrary cut-
off value between the two exposure groups of 0.04 mg/m3·yr over the past 3 months to an annual average, this 
threshold level might lie between 0.1 and 0.2 mg/m3·yr for annual Mn exposure. Follow-up studies to investigate 
a more accurate threshold of effect, and how the GABA levels change with the individual exposure longitudinally 
will be of high interest to provide further dynamic information and knowledge on how the GABAergic system 
responds to changes in Mn exposure individually.  
The neuronal pathways in the basal ganglia and the thalamus, as illustrated in Fig. 7, reveal the interaction 
between the GABAergic and dopaminergic system. As reviewed by Guilarte (2010), the general findings on how 
Mn exposure affects the dopaminergic system suggest a decreased D2-receptor level in the striatum in the 
absence of change in D1-receptor levels and dopamine levels. The disinhibition of the indirect pathway is known 
to inhibit ongoing movement (DeLong and Wichmann, 2007). Thus, the elevation of GABA levels in the thalamus 
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rather than the striatum is in line with the above conclusions: since D2-receptors inhibit the indirect pathway 
(Neves et al. 2002), reduction in the number of striatal D2-receptors will cause stronger inhibition to the thalamus 
and thus higher thalamic GABA levels. However, further investigations are necessary to verify this hypothesis. 
--------------------------------------- 
-------------------------------------- 
The results of the regression analysis of the GABA levels as response to individual exposure levels suggest that 
the increase of the thalamic GABA levels is most strongly dependent on the past-12-months Mn exposure. Our 
data further suggests that this response of thalamic GABA levels to individual Mn exposure over the past year 
may support the threshold theory: as seen in the scatterplot in Fig. 4, the higher exposed welders are driving this 
correlation, whereas LEX welders might not show much of a correlation with GABA at all. In comparison, life-
time cumulative exposure levels did not seem to be associated with thalamic GABA levels. The reason could be 
that the establishment of a Mn equilibrium (Nong et al., 2008) in the brain is more dependent on the short-term 
exposure levels rather than life-long exposure levels. Though the half-life of Mn in human brain, especially the 
basal ganglia region has not been determined, Taketa et al. (1995) reported the Mn half-life between 51-74 days 
in rat brain tissue.  In a study conducted by Erikson et al. (2007) on rhesus monkeys, excessive Mn deposition 
in the brain recovered to normal level 45-90 days after inhalation. This time frame agrees with our result of 
significant correlations between the thalamic GABA levels and short-term (past-12-months, past-3-months) 
exposure levels. The significant correlation between past-12-months exposure and thalamic GABA levels 
suggests that the effect of Mn on the neurochemical system could last somewhat longer in humans.  
R1 values were found to be generally elevated in welders, indicating a larger amount of Mn deposition. 
Consistent with the sequential transport of Mn from striatum to pallidum-substantia nigra reported by Saleem et 
al. (2002), increased R1 values in the globus pallidus and substantia nigra were observed. The higher Mn 
deposition in frontal cortex found in welders is in line with rodent studies by Elder et al. (2006), which is likely to 
be a result of axonal transport of Mn from the striatum via the substantia nigra to the frontal cortex studied with 
manganese enhanced MRI (Paulter et al. 2003). Studies on Mn-exposed smelters by Long et al. (2014a) also 
demonstrated the vulnerability of frontal cortex to Mn exposure. 
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It is worth noting that there was no statistically significant difference in R1 values between HEX and LEX groups 
(globus pallidus: p = 0.07; caudate nucleus: p = 0.40; frontal cortex: p = 0.90; substantia nigra: p = 0.09). There 
was no correlation between exposure levels and R1 values from any of the investigated brain regions either as 
shown in Table 2.1. This suggests that although brain Mn accumulation after chronic exposure to Mn can be 
observed, the quantitative relationship between inhaled Mn and brain Mn is not straightforward. Mn transport 
into the CNS is a complex process which is known to involve crossing the blood brain barrier and choroid plexus, 
or intra-axonal uptake through olfactory nerve endings (Aschner et al., 2005; Yokel, 2009). Therefore, a more 
refined model including the bio-kinetic properties of Mn accumulation is suggested to be applied to better 
understand the relationship between brain Mn deposition and inhaled Mn levels. 
In our study, the thalamic GABA levels were found to be significantly affected by Mn deposition in the substantia 
nigra. As shown in Fig. 7, the substantia nigra has GABAergic projections to the thalamus and dopaminergic 
projections to the striatum. Nigrostriatal dopaminergic neuronal pathways have been known to be affected by 
Mn neurotoxicity (Sloot and Gramsbergen, 1994; Erikson et al., 2005), while the effect on nigrothalamo pathways 
is not clear. Our result suggests that as one of the targets for excessive Mn deposition in the brain, the substantia 
nigra may be involved in the disruption of the GABAergic system by affecting the neuronal communication with 
the thalamus and further inhibiting thalamo-cortical projections. This would be in line with increased thalamic 
GABA levels, as well as increased hypokinetic symptoms such as rigidity. In addition, the R1 values in the globus 
pallidus also significantly, but negatively, predicted the thalamic GABA levels in welders. This negative 
correlation is not easy to explain with the same simplistic model of pathways as demonstrated in Fig.7 and will 
need further investigation.   
The striatal GABA levels were significantly associated with Mn deposition in the frontal cortex. This could be 
explained by the direct projection from the frontal cortex to the striatum. As presented in the results, the 
correlation between the striatal GABA levels and R1 values from the substantia nigra is likely due to a 
multicollinearity issue. Thus, we do not suggest any association between Mn deposition in the substantia nigra 
and striatal GABA levels.  
As a common clinical manifestation for IPD and manganism (Olanow, 2004), rigidity has been reported to be 
closely associated with the basal ganglia and the thalamus (Silkis, 2001).  However, in our study, the level of 
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rigidity in the welders was not significantly different from controls. One possible reason could be that the exposure 
levels of the welders were not high enough to cause clinically observable adversity in rigidity. As clinical rating 
scale for a more severe movement dysfunction in Parkinson’s disease, the UPDRS scale also might not be 
sensitive enough to pick up very subtle changed in motor dexterity. Another reason could be that the demand of 
fine movements in the welding process and frequent practice of such movements, which further requires a good 
coordination of various motor control centers in the brain, compensate the slightly increased rigidity, if there is 
any, in the welders (healthy worker effect). 
The findings that no resting tremor was found in any subject and that only slightly but significantly more kinetic 
tremor was found in welders with higher exposure levels agree with the clinical reports on the symptoms of Mn-
induced parkinsonism. However, our data does not suggest any direct association between GABA levels in the 
thalamus or striatum and the severity of tremor in Mn exposed subjects. One possibility is that the tremor levels 
of the welders recruited in this study were still in a normal range. The variation of the tremor scores were not 
directly controlled by GABA levels. In addition, the complexity of the mechanism of the tremor suggests that the 
basal ganglia are not the only brain areas associated with tremor. Therefore, such a regression analysis would 
over-simplify the association between GABA levels and tremor levels.   
There are several limitations of this study. First, the effect of iron, which is another highly concentrated metal 
present in welding fume (Li et al., 2004), was not taken into account in this analysis.  In most occupational 
exposure studies on Mn, co-exposure to iron has been ignored to date. However, the toxic effects of Mn on the 
CNS are known to be associated and interacting with iron due to their chemical similarities (Antonini et al., 2006). 
In this study, it is assumed that the reported findings were mostly related to Mn mainly because the iron exposure 
levels from the welders recruited for this study (mean (SD): 1.273 (0.522) mg/m3, ranging from 0.072 to 2.314 
mg/m3) were much lower than the exposure limit of iron recommended by the ACGIH TLV (5 mg/m3). Another 
limitation is that the direct impact of Mn accumulation on neuronal pathways and connections, especially on the 
neuronal activities of the substantia nigra, could not be directly detected using the current techniques. Therefore, 
our interpretations of the correlation between Mn deposition in the substantia nigra and thalamic GABA levels 
will need verification with other methods in the future. 
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In summary, in our study, a significant elevation of GABA levels in the thalamus of Mn-exposed welders was 
observed. Importantly, this study suggests that the increase of thalamic GABA levels only occurs when the 
exposure level is higher than a certain threshold, which is likely around 0.1 mg/m3 respirable airborne Mn 
concentration. Furthermore, the elevated GABA levels were dependent both on past-12-months and past-3-
months individual exposure levels, and directly associated with Mn deposition in the substantia nigra and the 
globus pallidus. Therefore, we suggest that the alteration of the thalamic GABA levels is a characteristic 
neurochemical response that links recent Mn exposure, as well as brain Mn deposition in the basal ganglia, to 
first effects on motor function. A next step is to test the reversibility of thalamic GABA levels when exposure to 
Mn is reduced, e.g. in compliance with the new ACGIH TLV of 0.02 mg/m3 airborne respirable Mn concentration. 
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Figure 1: Distribution of past-3-months individual exposure levels across welders. The red line indicates the 
dividing line between welders with higher exposure (HEX) and lower exposure (LEX) 
Figure 2: Thalamus a) and striatum b) VOI for GABA measurements shown on sagittal and AC-PC aligned views 
on T2-weighted images, and on an axial view of a brain tissue map (red: white matter, blue: grey matter, green: 
CSF). Please note the tissue maps have a slightly different angulation from the AC-PC aligned T2-weighted 
images. Also shown are typical GABA-edited spectra from thalamus (top) and striatum (bottom) fitted with 
LCModel (red lines).  
Figure 3. Regions of Interest (ROIs) of T1 value measurement in a) left and right globus pallidus (green) and 
caudate nucleus (cyan); b) left and right frontal cortex (blue); c) left and right substantia nigra (red).  
Figure 4. Example of T1 hyperintensity in the globus pallidus (GP) (red arrows) of a welder (left), compared to 
an unexposed control subject (right), displaying the mean R1 values from the GP for each subject. 
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Figure 5. Group comparisons across controls (CT), welders with higher exposure (HEX) and with lower exposure 
(LEX): a) past-3-months and b) lifetime cumulative exposure levels; R1 values in c) the globus pallidus, d) 
substantia nigra and e) frontal cortex; f) thalamic and g) striatal GABA levels; h) UPDRS total score, i) UPDRS 
rigidity score and j) UPDRS tremor score; *,**,***: p<0.05, p<0.01, p<0.001 
Figure 6. Scatter plot of thalamic GABA levels vs. past-12-months exposure levels for all welders 
Figure 7. Schematic diagram of basal ganglia-thalamo-cortical circuit. Blue, red and green arrows indicate 
dopaminergic, GABAergic and glutamatergic projections respectively. SNc: substantia nigra pars compacta, SNr: 
substantia nigra pars reticulata, GPe: globus pallidus external, GPi: globus pallidus internal, STN: subthalamic 
nucleus, D1 and D2: dopamine receptors D1 and D2.  
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***, p<0.001 for comparison between each Mn-exposed group and controls 
#, p<0.05 for comparison between welders with higher exposure (HEX) and lower exposure 
(LEX) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Age, years of education, airborne respirable Mn, and mean years of Mn exposure for each group of the 
subjects, listed as mean (standard deviation) 
 Controls Welders LEX Welders HEX Welders 
Number 22 39 26 13 
Mean age 40 (12) 40 (11) 39 (11) 44 (10) 
Mean years of education 13 (2) 13(2) 13 (2) 14 (2) 
Mean airborne respirable Mn [mg/m3] 0.002 (0.001)  0.17 (0.14)*** 0.13 (0.10)*** 0.23 (0.18)***,# 
Mean years of exposure 0 12 (9) 11 (7) 16 (10) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* ,**,*** p<0.05, p<0.01, p<0.001 for comparison to the control group 
#,##,###, p<0.05, p<0.01, p<0.001 for comparison between welders with higher exposure (HEX) and lower exposure (LEX) 
 
 
 
 
 
Table 2. Group comparisons of GABA levels, individual exposure levels with three exposure windows, R1 values and UPDRS 
scores with rigidity and tremor scores, listed as mean (standard deviation) for each group.  
 Controls Welders LEX Welders HEX Welders 
Exposure levels ((mg/m3)·yr)     
Past-3-Month 0.000 (0.000) 0.037 (0.033)*** 0.021 (0.010)*** 0.069 (0.040)***,### 
Past-12-Month 0.002 (0.001) 0.174 (0.142)*** 0.108 (0.090)*** 0.307 (0.135)***,### 
Cumulative 0.040 (0.035) 1.886 (1.664)*** 1.448 (1.510)*** 2.763 (1.665)***,# 
GABA levels (mM)     
Thalamic GABA  1.563 (0.638) 1.881 (0.829) 1.624 (0.670) 2.395 (0.900)**,## 
Striatal GABA  1.922 (0.606) 1.684 (0.403) 1.656 (0.422) 1.743 (0.370) 
R1 values (1/s)     
Globus Pallidus 0.869 (0.096) 0.986 (0.154)** 0.955 (0.119)** 1.049 (0.198)*** 
Substantia Nigra 0.800 (0.136) 0.858 (0.124) 0.834 (0.128) 0.906 (0.102)* 
Caudate Nucleus 0.704 (0.083) 0.764 (0.103)* 0.754 (0.106) 0.784 (0.096)* 
Frontal Cortex 0.915 (0.136) 1.074 (0.225)** 1.078 (0.243)** 1.068 (0.192)** 
UPDRS     
Total Score 5.0 (3.2) 7.9 (5.0)* 6.8 (4.4) 10.2 (5.7)** 
Rigidity 2.6 (1.7) 2.1 (1.5) 2.1 (1.7) 2.0 (1.2) 
Tremor 0.6 (0.9) 0.7 (1.0) 0.5 (0.9) 1.3 (0.9)* ,## 
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Table 3.1 Pearson correlations between GABA levels, exposure levels, brain R1 values and age, listed as correlation coefficients 
( r ) and p values (p) 
  GABA (Str) Exp (P3M) Exp (P12M) Exp (CUM) R1 (GP) R1 (CN) R1 (FT) R1 (SN) Age 
GABA (Thal) r 0.24 0.37 0.47 0.25 -0.03 0.05 0.34 0.51 0.21 
 p 0.15 0.02 0.002 0.12 0.84 0.76 0.04 0.001 0.19 
GABA (Str) r  -0.003 0.14 0.09 0.13 0.11 0.56 0.341 0.16 
 p  0.98 0.40 0.60 0.44 0.51 0.0003 0.04 0.34 
Exp (P3M) r   0.77 0.27 0.11 -0.03 -0.02 0.22 -0.05 
 p   <0.0001 0.10 0.50 0.88 0.90 0.17 0.75 
Exp (P12M) r    0.29 0.04 -0.05 -0.05 0.25 0.02 
 p    0.07 0.80 0.78 0.78 0.12 0.91 
Exp (CUM) r     0.07 -0.06 -0.01 0.12 0.43 
 p     0.65 0.71 0.95 0.47 0.006 
R1 (GP) r      0.80 0.40 0.63 0.26 
 p      <0.0001 0.01 <0.0001 0.11 
R1 (CN) r       0.54 0.66 -0.01 
 p       0.0003 <0.0001 0.94 
R1 (FT) r        0.75 -0.12 
 p        <0.0001 0.45 
R1 (SN) r         0.13 
 p         0.42 
GABA (Thal): thalamic GABA levels; GABA (Str): striatal GABA levels; Exp (P3M): past-3-month exposure levels; Exp (P12M): 
past-12-months exposure levels; Exp (CUM): cumulative exposure levels; R1 (GP): R1 values from the globus pallidus; R1(CN): 
R1 values from the caudate nucleus; R1 (FT): R1 values from the frontal cortex; R1 (SN): R1 values from the substantia nigra 
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Table 3.2 Pearson correlations between GABA levels, UPDRS total score, rigidity, 
tremor and age, listed as correlation coefficients (r) and p values (p) 
  GABA (Str) UPDRS  Rigidity Tremor Age 
GABA (Thal) r 0.24 0.16 0.22 0.15 0.21 
 p 0.15 0.32 0.17 0.37 0.19 
GABA (Str) r  -0.02 -0.06 0.08 0.16 
 p  0.92 0.72 0.63 0.34 
UPDRS  r   0.50 0.61 0.45 
 p   0.001 <0.0001 0.004 
Rigidity r    0.10 0.24 
 p    0.55 0.15 
Tremor r     0.32 
 p     0.05 
GABA (Thal): thalamic GABA levels; GABA (Str): striatal GABA levels; UPDRS: 
UPDRS III total scores; Rigidity: Rigidity scores; Tremor: Tremor scores 
 
 
 
Table 4.1 Type III SS analysis of each variable in the 
full model of regression on the thalamic GABA levels 
Source Type III SS F Value p Value 
R1 (GP) 3.28 10.43 0.003 
R1 (CN) 0.10 0.3 0.59 
R1 (FT) 0.13 0.41 0.53 
R1 (SN) 2.23 7.08 0.01 
Age 1.54 4.92 0.03 
Exp (P12M) 2.06 6.54 0.02 
Exp (CUM) 0.0005 0.00 0.97 
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Table 4.2 Type III SS analysis of each variable in the 
full model of regression on the striatal GABA levels 
Source Type III SS F Value p Value 
R1 (GP) 0.00002 0.00 0.99 
R1 (CN) 0.03 0.27 0.61 
R1 (FT) 2.03 20.14 0.0001 
R1 (SN) 0.27 2.64 0.12 
Age 0.51 5.11 0.03 
Exp (P12M) 0.31 3.05 0.09 
Exp (CUM) 0.06 0.61 0.44 
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Table 4.3 Results from the final model for regression analysis of the thalamic GABA levels on 
exposure levels and R1 values 
Model Summary 
 df (model) df (error) Adj R-square F value p value   
 4 34 0.57 13.76 <0.0001   
Coefficient Estimation 
 Variable Parameter 
Estimation 
t Value p value VIF CI_upper CI_lower 
 Exp (P12M) 1.72 2.66 0.01 1.10 3.03 0.41 
 R1 (GP) -3.26 -4.28 0.0001 1.79 -1.71 -4.81 
 R1 (SN) 5.26 5.5 <0.0001 1.81 7.20 3.32 
 Age 0.02 2.39 0.02 1.08 0.037 0.003 
 
 
 
Table 4.4 Results from the final model for regression analysis of the striatal GABA levels on 
exposure levels and R1 values 
Model Summary 
 df (model) df (error) Adj R-square F value p value   
 4 32 0.48 7.46 0.0002   
Coefficient Estimation 
 Variable Parameter 
Estimation 
t Value p value VIF CI_upper CI_lower 
 Exp (P12M) 0.89 1.96 0.06 1.33 1.81 -0.03 
 R1 (FT) 1.81 4.66 <0.0001 3.04 2.61 1.02 
 R1 (SN) -1.80 -2.42 0.02 3.35 -0.28 -3.32 
 Age 0.01 2.5 0.02 1.16 0.02 0.002 
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Table 5.1 Type III SS analysis of each variable in the 
full model of regression on UPDRS total score 
Source Type III SS F value p Value 
GABA (Thal) 11.08 0.49 0.49 
GABA (Str) 11.05 0.49 0.49 
Age 157.66 7.01 0.01 
 
Table 5.2 Results from the final model for regression analysis of UPDRS total 
scores on GABA levels and age 
Model summary 
 df (model) df (error) Adj R-square F value p value  
 1 37 0.18 9.44 0.004  
Coefficient estimation 
 Variable Parameter 
Estimation 
t Value p value CI_upper CI_lower 
 Age 0.21 3.07 0.004 0.35 0.07 
 
Table 5.3 Type III SS analysis of each variable in the 
full model of regression on rigidity score 
Source Type III SS F Value p Value 
GABA (Thal) 3.75 1.59 0.22 
GABA (Str) 1.68 0.71 0.41 
Age 2.96 1.25 0.27 
 
Table 5.4 Type III SS analysis of each variable in the 
full model of regression on tremor score 
Source Type III SS F Value p Value 
GABA (Thal) 0.03 0.03 0.86 
GABA (Str) 0.02 0.02 0.89 
Age 3.16 3.52 0.07 
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